All Stories

  1. The PYRIN domain is required for TLR4-mediated inflammation by PYHIN family members
  2. Red‐Light Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue
  3. Red-Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
  4. Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection
  5. Clodronate Reduces ATP-Containing Microvesicle Releasing Induced by Nociceptive Stimuli in Human Keratinocytes
  6. Antimicrobial Efficacy of a Vegetable Oil Plasticizer in PVC Matrices
  7. Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells
  8. Red-Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
  9. Antiherpetic Activity of a Root Exudate from Solanum lycopersicum
  10. Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors
  11. Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro
  12. Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8‒Transgenic Mice
  13. SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes
  14. Induction of robust humoral immunity against SARS‐CoV‐2 after vaccine administration in previously infected haematological cancer patients
  15. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
  16. Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients
  17. Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study
  18. Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity
  19. SARS‐CoV‐2 reinfection in a cancer patient with a defective neutralizing humoral response
  20. Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
  21. Human cytomegalovirus-induced host protein citrullination is crucial for viral replication
  22. Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids
  23. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ
  24. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story
  25. Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding
  26. Mass Spectrometry-Based Characterization of the Virion Proteome, Phosphoproteome, and Associated Kinase Activity of Human Cytomegalovirus
  27. Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection
  28. Tuning the Orchestra: HCMV vs. Innate Immunity
  29. Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis
  30. IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data
  31. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes
  32. Serum IFI16 and anti‐IFI16 antibodies in psoriatic arthritis
  33. Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease
  34. The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity
  35. Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children
  36. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity
  37. The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes
  38. β-HPV Infection Correlates with Early Stages of Carcinogenesis in Skin Tumors and Patient-Derived Xenografts from a Kidney Transplant Recipient Cohort
  39. HPV18 Persistence Impairs Basal and DNA Ligand–Mediated IFN-β and IFN-λ1Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling
  40. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING
  41. HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion
  42. Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy
  43. Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability
  44. Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape
  45. ID: 37
  46. ID: 216
  47. Identification of the skin virome in a boy with widespread human papillomavirus‐2‐positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine
  48. The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation
  49. The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters
  50. Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity
  51. IFI16Expression Is Related to Selected Transcription Factors during B-Cell Differentiation
  52. Analysis of human β-papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of patients with chronic lymphocytic leukaemia
  53. Serological Evidence of Batai Virus Infections, Bovines, Northern Italy, 2011
  54. α- and β-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions
  55. Erratum: Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients
  56. Restriction factors against human CMV
  57. Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage
  58. Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients
  59. IFI16 Autoantibodies
  60. 17
  61. Nuclear DNA Sensor IFI16 as Circulating Protein in Autoimmune Diseases Is a Signal of Damage that Impairs Endothelial Cells through High-Affinity Membrane Binding
  62. Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus
  63. The US16 Gene of Human Cytomegalovirus Is Required for Efficient Viral Infection of Endothelial and Epithelial Cells
  64. Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 Gene
  65. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models
  66. The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication
  67. PS1-018 . Human Cytomegalovirus induces redistribution of the interferon inducible protein IFI16 from nucleus to cytoplasm
  68. CS16-2. The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication
  69. Tumor-Derived Endothelial Cells Evade Apoptotic Activity of the Interferon-Inducible IFI16 Gene
  70. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing
  71. The Multifaceted Interferon-Inducible p200 Family Proteins: From Cell Biology to Human Pathology
  72. SS10-8 The interferon-inducible IFI16 gene acts as a restriction factor for human cytomegalovirus replication
  73. Keratinocyte-Specific Stat3 Heterozygosity Impairs Development of Skin Tumors in Human Papillomavirus 8 Transgenic Mice
  74. The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity
  75. The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response
  76. In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16
  77. High prevalence of human cytomegalovirus in a population of periodontally healthy subjects
  78. Disruption of epidermal specific Stat3 expression and delayed skin tumor development in HPV8 transgenic mice
  79. The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway
  80. The epithelial–mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: Characterization of global transcription profiles
  81. High β-HPV DNA Loads and Strong Seroreactivity Are Present in Epidermodysplasia Verruciformis
  82. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression
  83. Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-α
  84. Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells
  85. 35 Role of the IFN-inducible gene IFI16 in the pathogenesis of autoimmune diseases
  86. Corrigendum to “Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis” [Gynecol. Oncol. 108 (2008) 112–120]
  87. Identification of Defective Fas Function and Variation of the Perforin Gene in an Epidermodysplasia Verruciformis Patient Lacking EVER1 and EVER2 Mutations
  88. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis
  89. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma–derived cell lines
  90. Role of the Interferon-Inducible Gene IFI16 in the Etiopathogenesis of Systemic Autoimmune Disorders
  91. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression
  92. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication
  93. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16
  94. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity
  95. VIGNETTES
  96. Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells
  97. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index
  98. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells
  99. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells
  100. Cell Cycle Arrest by Human Cytomegalovirus 86-kDa IE2 Protein Resembles Premature Senescence
  101. The Mouse Interferon-Inducible Gene Ifi204 Product Interacts with the Tpr Protein, a Component of the Nuclear Pore Complex
  102. Immunohistochemical Expression Analysis of the Human Interferon-Inducible Gene IFI16, a Member of the HIN200 Family, Not Restricted to Hematopoietic Cells
  103. The interferon system: an overview
  104. The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites
  105. The Interferon-Inducible 204 Gene Is Transcriptionally Activated by Mouse Cytomegalovirus and Is Required for Its Replication
  106. The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase
  107. Chemohyperthermia for advanced abdominal malignancies: a new procedure with closed abdomen and previously performed anastomosis
  108. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation
  109. Murine Cytomegalovirus Stimulates Cellular Thymidylate Synthase Gene Expression in Quiescent Cells and Requires the Enzyme for Replication
  110. Melusin Is a New Muscle-specific Interactor for  1Integrin Cytoplasmic Domain
  111. The Interferon-Inducible 204 Gene, a Member of the Ifi 200 Family, Is Not Involved in the Antiviral State Induction by IFN-α, but Is Required by the Mouse Cytomegalovirus for Its Replication
  112. The HMG Protein T160 Colocalizes with DNA Replication Foci and Is Down-regulated during Cell Differentiation
  113. The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains
  114. Molecular and Cellular Guidance of Neuronal Migration in the Developing Olfactory System of Rodents
  115. Prenatal differentiation of mouse vomeronasal neurones